Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Screening for type 2 diabetes in a high-risk population: study design and feasibility of a population-based randomized controlled trial.

Klijs B, Otto SJ, Heine RJ, van der Graaf Y, Lous JJ, de Koning HJ.

BMC Public Health. 2012 Aug 17;12:671. doi: 10.1186/1471-2458-12-671.

3.

[Detection of metabolic syndrome by self-measurement of waist circumference].

den Engelsen C, van den Donk M, Gorter KJ, Salomé PL, Bobbink IW, Rutten GE.

Ned Tijdschr Geneeskd. 2010;154:A1028. Dutch.

PMID:
20456761
4.

Parental history of diabetes modifies the association between abdominal adiposity and hyperglycemia.

van Dam RM, Boer JM, Feskens EJ, Seidell JC.

Diabetes Care. 2001 Aug;24(8):1454-9.

PMID:
11473086
5.

Irish diabetes detection programme in general practice.

Smith SM, Holohan J, McAuliffe A, Firth RG.

Diabet Med. 2003 Sep;20(9):717-22.

PMID:
12925050
6.

Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS).

Hosseinpanah F, Rambod M, Reza Ghaffari HR, Azizi F.

Diabet Med. 2006 Sep;23(9):982-9.

PMID:
16922704
7.

A more simplified Finnish diabetes risk score for opportunistic screening of undiagnosed type 2 diabetes in a German population with a family history of the metabolic syndrome.

Li J, Bergmann A, Reimann M, Bornstein SR, Schwarz PE.

Horm Metab Res. 2009 Feb;41(2):98-103. doi: 10.1055/s-0028-1087191. Epub 2008 Oct 29.

PMID:
18975253
8.
9.

Prescreening tools for diabetes and obesity-associated dyslipidaemia: comparing BMI, waist and waist hip ratio. The D.E.S.I.R. Study.

Balkau B, Sapinho D, Petrella A, Mhamdi L, Cailleau M, Arondel D, Charles MA; D.E.S.I.R. Study Group.

Eur J Clin Nutr. 2006 Mar;60(3):295-304.

10.
11.

Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.

Creagh D, Neilson S, Collins A, Colwell N, Hinchion R, Drew C, O'Halloran D, Perry IJ.

Ir Med J. 2002 Nov-Dec;95(10):298-301.

PMID:
12542011
12.

Waist-to-height ratio and cardiovascular risk factors in elderly individuals at high cardiovascular risk.

Guasch-Ferré M, Bulló M, Martínez-González MÁ, Corella D, Estruch R, Covas MI, Arós F, Wärnberg J, Fiol M, Lapetra J, Muñoz MÁ, Serra-Majem L, Pintó X, Babio N, Díaz-López A, Salas-Salvadó J.

PLoS One. 2012;7(8):e43275. doi: 10.1371/journal.pone.0043275. Epub 2012 Aug 14.

13.

Screening for type 2 diabetes in a high-risk population: effects of a negative screening test after 4 years follow-up.

Willems JI, Otto SJ, Klijs B, de Koning HJ.

Ann Behav Med. 2014 Feb;47(1):102-10. doi: 10.1007/s12160-013-9525-3.

PMID:
23818042
14.

Development of a new scoring system for predicting the 5 year incidence of type 2 diabetes in Japan: the Toranomon Hospital Health Management Center Study 6 (TOPICS 6).

Heianza Y, Arase Y, Hsieh SD, Saito K, Tsuji H, Kodama S, Tanaka S, Ohashi Y, Shimano H, Yamada N, Hara S, Sone H.

Diabetologia. 2012 Dec;55(12):3213-23. doi: 10.1007/s00125-012-2712-0. Epub 2012 Sep 7.

PMID:
22955996
15.

Scaling-up from an implementation trial to state-wide coverage: results from the preliminary Melbourne Diabetes Prevention Study.

Janus ED, Best JD, Davis-Lameloise N, Philpot B, Hernan A, Bennett CM, O'Reilly S, Carter R, Vartiainen E, Dunbar JA; Melbourne Diabetes Prevention Study research group.

Trials. 2012 Aug 28;13:152. doi: 10.1186/1745-6215-13-152.

16.

Yield of opportunistic targeted screening for type 2 diabetes in primary care: the diabscreen study.

Klein Woolthuis EP, de Grauw WJ, van Gerwen WH, van den Hoogen HJ, van de Lisdonk EH, Metsemakers JF, van Weel C.

Ann Fam Med. 2009 Sep-Oct;7(5):422-30. doi: 10.1370/afm.997.

17.

Effectiveness of a hospital-based vascular screening programme (SMART) for risk factor management in patients with established vascular disease or type 2 diabetes: a parallel-group comparative study.

Brouwer BG, Visseren FL, Algra A, van Bockel JH, Bollen EL, Doevendans PA, Greving JP, Kappelle LJ, Moll FL, Pijl H, Romijn JA, van der Wall EE, van der Graaf Y.

J Intern Med. 2010 Jul;268(1):83-93. doi: 10.1111/j.1365-2796.2010.02229.x. Epub 2010 Mar 3.

18.

A simple pragmatic system for detecting new cases of type 2 diabetes and impaired fasting glycaemia in primary care.

Greaves CJ, Stead JW, Hattersley AT, Ewings P, Brown P, Evans PH.

Fam Pract. 2004 Feb;21(1):57-62.

PMID:
14760046
19.

Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D).

Saaristo T, Moilanen L, Jokelainen J, Korpi-Hyövälti E, Vanhala M, Saltevo J, Niskanen L, Peltonen M, Oksa H, Cederberg H, Tuomilehto J, Uusitupa M, Keinänen-Kiukaanniemi S.

Prim Care Diabetes. 2010 Dec;4(4):231-9. doi: 10.1016/j.pcd.2010.05.005. Epub 2010 Jun 18.

PMID:
21134669
20.

Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: The Hoorn Screening Study.

Adriaanse MC, Dekker JM, Spijkerman AM, Twisk JW, Nijpels G, van der Ploeg HM, Heine RJ, Snoek FJ.

Qual Life Res. 2005 Aug;14(6):1501-9.

PMID:
16110930

Supplemental Content

Support Center